piritrexim has been researched along with Local Neoplasm Recurrence in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bedford, P; Bleehen, NM; Nethersell, AB; Newman, HV; Rampling, RP; Ramsay, JR; Roberts, JT | 1 |
Cvitkovic, E; Domenge, C; Gandia, D | 1 |
Clendeninn, NJ; Collier, MA; Dimery, IW; Eble, ML; Jacobs, CD; Karp, D; Molina, A; Vokes, EE | 1 |
2 trial(s) available for piritrexim and Local Neoplasm Recurrence
Article | Year |
---|---|
A phase II study of oral piritrexim in recurrent high-grade (III, IV) glioma.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Drug Administration Schedule; Female; Folic Acid Antagonists; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pyrimidines | 1995 |
A phase II study of piritrexim in combination with methotrexate in recurrent and metastatic head and neck cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Drug Administration Schedule; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Pyrimidines | 1991 |
1 other study(ies) available for piritrexim and Local Neoplasm Recurrence
Article | Year |
---|---|
Case report of acquired piritrexim resistance and collateral methotrexate sensitivity in recurrent squamous cell carcinoma of the head and neck.
Topics: Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Resistance; Folic Acid Antagonists; Head and Neck Neoplasms; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Pyrimidines | 1993 |